Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China · Delayed Price · Currency is CNY 9.78
-0.10 (-1.01%)
Jun 11, 2026, 3:04 PM CST
SHE:002900 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,126 | 3,857 | 3,049 | 4,228 | 4,229 | 6,453 | |
Market Cap Growth | -12.20% | 26.48% | -27.88% | -0.01% | -34.47% | 125.19% |
Enterprise Value | 3,668 | 4,164 | 3,126 | 3,815 | 3,675 | 6,009 |
Last Close Price | 9.88 | 12.46 | 9.71 | 13.19 | 13.09 | 19.47 |
PE Ratio | - | - | 51.97 | 57.40 | 139.99 | 18.39 |
Forward PE | - | 40.26 | 40.26 | 40.26 | 40.26 | 40.26 |
PS Ratio | 3.84 | 4.89 | 2.69 | 3.56 | 4.11 | 6.82 |
PB Ratio | 1.77 | 2.17 | 1.41 | 1.97 | 2.06 | 3.05 |
P/TBV Ratio | 1.91 | 2.35 | 1.49 | 2.09 | 2.14 | 3.18 |
P/FCF Ratio | - | - | - | - | 76.30 | - |
P/OCF Ratio | - | - | 99.37 | 118.45 | 29.24 | - |
EV/Sales Ratio | 4.51 | 5.28 | 2.76 | 3.22 | 3.57 | 6.35 |
EV/EBITDA Ratio | - | - | 23.40 | 42.19 | 56.52 | - |
EV/EBIT Ratio | - | - | 95.56 | - | - | - |
EV/FCF Ratio | - | - | - | - | 66.31 | - |
Debt / Equity Ratio | 0.58 | 0.63 | 0.43 | 0.33 | 0.32 | 0.23 |
Debt / EBITDA Ratio | - | - | 6.49 | 7.13 | 8.80 | - |
Debt / FCF Ratio | - | - | - | - | 11.85 | - |
Net Debt / Equity Ratio | 0.31 | 0.29 | 0.04 | -0.15 | -0.31 | -0.29 |
Net Debt / EBITDA Ratio | -2.91 | -2.59 | 0.70 | -3.65 | -9.80 | 10.36 |
Net Debt / FCF Ratio | -1.75 | -1.79 | -0.30 | 1.25 | -11.50 | 7.21 |
Asset Turnover | 0.23 | 0.22 | 0.31 | 0.35 | 0.32 | 0.34 |
Inventory Turnover | 1.97 | 1.95 | 2.15 | 2.57 | 2.27 | 1.82 |
Quick Ratio | 0.58 | 0.61 | 0.86 | 1.36 | 2.38 | 2.32 |
Current Ratio | 0.88 | 0.87 | 1.17 | 1.70 | 2.72 | 2.66 |
Return on Equity (ROE) | -16.38% | -17.34% | 2.55% | 3.34% | 1.27% | 17.89% |
Return on Assets (ROA) | -5.79% | -5.66% | 0.56% | -0.15% | -0.63% | -3.38% |
Return on Invested Capital (ROIC) | -14.24% | -14.46% | 1.47% | -0.43% | -1.45% | -9.15% |
Return on Capital Employed (ROCE) | -14.10% | -14.20% | 1.30% | -0.30% | -1.20% | -5.90% |
Earnings Yield | -10.17% | -8.81% | 1.92% | 1.74% | 0.71% | 5.44% |
FCF Yield | -9.88% | -7.36% | -10.35% | -6.24% | 1.31% | -1.34% |
Dividend Yield | 2.02% | - | 2.06% | 1.52% | 0.76% | 1.64% |
Payout Ratio | - | - | 178.20% | 55.71% | 361.96% | 9.78% |
Buyback Yield / Dilution | -4.78% | -2.78% | -0.61% | -1.61% | 2.74% | 4.68% |
Total Shareholder Return | -2.75% | -2.78% | 1.44% | -0.09% | 3.50% | 6.33% |